Literature DB >> 24417454

Angina pectoris: current therapy and future treatment options.

Raj Parikh1, Philip J Kadowitz.   

Abstract

Angina pectoris is the consequence of an inequality between the demand and supply of blood to the heart. Angina manifests itself as chest pain or discomfort and is a common complaint of patients in the hospital and in the clinic. There are, in fact, roughly half a million new cases of angina per year. Chest pain, while having many etiologies, is generally considered to be most lethal when related to a cardiac cause. In this review, the authors outline the current medical and surgical therapies that are used in the management of angina. Highlights of the various clinical trials that have assisted in the investigation of these therapies are summarized also. Then, the authors provide a focused review of the novel therapy options for angina that are currently being explored. From new medical treatments to revised surgical techniques to the discovery of stem cell therapy, many innovative options are being investigated for the treatment of angina.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24417454     DOI: 10.1586/14779072.2014.880339

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  4 in total

Review 1.  Danshen injection as adjuvant treatment for unstable angina pectoris: A systematic review and meta-analysis.

Authors:  Jia-Rui Wu; Shi Liu; Xiao-Meng Zhang; Bing Zhang
Journal:  Chin J Integr Med       Date:  2016-12-05       Impact factor: 1.978

Review 2.  The usefulness of xuefu zhuyu tang for patients with angina pectoris: a meta-analysis and systematic review.

Authors:  Guo-Zhong Yi; Yu-Qin Qiu; Ya Xiao; Li-Xia Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-31       Impact factor: 2.629

3.  Dazhu Hongjingtian (Herba Rhodiolae) for unstable angina pectoris: Protocol for a systematic review and meta-analysis.

Authors:  Yu Fan; Xuyu Gu; Heng Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

4.  Dazhu Hongjingtian Preparation as Adjuvant Therapy for Unstable Angina Pectoris: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Changfeng Man; Zhe Dai; Yu Fan
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.